These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8654369)

  • 61. Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B.
    Maruyama S; Iwashita T; Imai T; Funahashi H; Ceccherini I; Luo Y; Romeo G; Matsuo S; Matsuyama M; Takahashi M
    Jpn J Cancer Res; 1994 Sep; 85(9):879-82. PubMed ID: 7961113
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease.
    Fitze G; Cramer J; Ziegler A; Schierz M; Schreiber M; Kuhlisch E; Roesner D; Schackert HK
    Lancet; 2002 Apr; 359(9313):1200-5. PubMed ID: 11955539
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation.
    Bongarzone I; Vigano E; Alberti L; Borrello MG; Pasini B; Greco A; Mondellini P; Smith DP; Ponder BA; Romeo G; Pierotti MA
    Oncogene; 1998 May; 16(18):2295-301. PubMed ID: 9620546
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations.
    Rossel M; Pasini A; Chappuis S; Geneste O; Fournier L; Schuffenecker I; Takahashi M; van Grunsven LA; Urdiales JL; Rudkin BB; Lenoir GM; Billaud M
    Oncogene; 1997 Jan; 14(3):265-75. PubMed ID: 9018112
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease.
    Dvoráková S; Dvoráková K; Malíková M; Skába R; Vlcek P; Bendlová B
    J Pediatr Surg; 2005 Jun; 40(6):e1-6. PubMed ID: 15991157
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice.
    Acton DS; Velthuyzen D; Lips CJ; Höppener JW
    Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence and parental origin of de novo RET mutations in Hirschsprung's disease.
    Yin L; Seri M; Barone V; Tocco T; Scaranari M; Romeo G
    Eur J Hum Genet; 1996; 4(6):356-8. PubMed ID: 9043870
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ultraviolet light induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases.
    Kato M; Iwashita T; Takeda K; Akhand AA; Liu W; Yoshihara M; Asai N; Suzuki H; Takahashi M; Nakashima I
    Mol Biol Cell; 2000 Jan; 11(1):93-101. PubMed ID: 10637293
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease.
    Salomon R; Attié T; Pelet A; Bidaud C; Eng C; Amiel J; Sarnacki S; Goulet O; Ricour C; Nihoul-Fékété C; Munnich A; Lyonnet S
    Nat Genet; 1996 Nov; 14(3):345-7. PubMed ID: 8896569
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A homozygous missense mutation in the tyrosine E kinase domain of the RET proto-oncogene in an infant with total intestinal aganglionosis.
    Shimotake T; Go S; Inoue K; Tomiyama H; Iwai N
    Am J Gastroenterol; 2001 Apr; 96(4):1286-91. PubMed ID: 11316186
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Point mutagenesis in mouse reveals contrasting pathogenetic effects between MEN2B- and Hirschsprung disease-associated missense mutations of the RET gene.
    Nakatani T; Iwasaki M; Yamamichi A; Yoshioka Y; Uesaka T; Bitoh Y; Maeda K; Fukumoto T; Takemoto T; Enomoto H
    Dev Growth Differ; 2020 May; 62(4):214-222. PubMed ID: 32275061
    [TBL] [Abstract][Full Text] [Related]  

  • 72. De-novo mutations of the RET proto-oncogene in Hirschsprung's disease.
    Pelet A; Attie T; Goulet O; Eng C; Ponder BA; Munnich A; Lyonnet S
    Lancet; 1994 Dec 24-31; 344(8939-8940):1769-70. PubMed ID: 7997019
    [No Abstract]   [Full Text] [Related]  

  • 73. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.
    Borrego S; Eng C; Sánchez B; Sáez ME; Navarro E; Antiñolo G
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3361-4. PubMed ID: 9745455
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A 7 bp deletion of the RET proto-oncogene in familial Hirschsprung's disease.
    Attie T; Pelet A; Sarda P; Eng C; Edery P; Mulligan LM; Ponder BA; Munnich A; Lyonnet S
    Hum Mol Genet; 1994 Aug; 3(8):1439-40. PubMed ID: 7987334
    [No Abstract]   [Full Text] [Related]  

  • 75. Within-gene interaction between c.135 G/A genotypes and RET proto-oncogene germline mutations in HSCR families.
    Fitze G; Cramer J; Serra A; Schreiber M; Roesner D; Schackert HK
    Eur J Pediatr Surg; 2003 Jun; 13(3):152-7. PubMed ID: 12939698
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.
    Melillo RM; Santoro M; Ong SH; Billaud M; Fusco A; Hadari YR; Schlessinger J; Lax I
    Mol Cell Biol; 2001 Jul; 21(13):4177-87. PubMed ID: 11390647
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
    Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
    Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma].
    Fehmann HC; Göke B
    Z Gastroenterol; 1994 Jul; 32(7):416-7. PubMed ID: 7975780
    [No Abstract]   [Full Text] [Related]  

  • 79. TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease.
    Garcia-Barcelo M; Ganster RW; Lui VC; Leon TY; So MT; Lau AM; Fu M; Sham MH; Knight J; Zannini MS; Sham PC; Tam PK
    Hum Mol Genet; 2005 Jan; 14(2):191-204. PubMed ID: 15548547
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.
    Mograbi B; Bocciardi R; Bourget I; Juhel T; Farahi-Far D; Romeo G; Ceccherini I; Rossi B
    Mol Cell Biol; 2001 Oct; 21(20):6719-30. PubMed ID: 11564857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.